|
|
Time Trends in Incidence of Motor Neuron Diseases in France: A Comprehensive 14‐Year Nationwide Study (2010–2023)
Octave Guinebretiere
,
Quentin Calonge
,
Gaëlle Bruneteau
,
Maria‐del‐mar Amador
,
Thomas Nedelec
Article dans une revue
hal-05039352
v1
|
|
|
Incidence, mortality, and management of status epilepticus from 2012 to 2022: An 11‐year nationwide study
Quentin Calonge
,
Aurélie Hanin
,
Edouard Januel
,
Octave Guinebretiere
,
Thomas Nedelec
et al.
Article dans une revue
hal-05276617
v1
|
|
|
Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis
Dang Wei
,
Anna Freydenzon
,
Octave Guinebretiere
,
Karim Zaidi
,
Fen Yang
et al.
Article dans une revue
hal-05028859
v1
|
|
|
Updated Multiple Sclerosis Incidence in France, 2011–2021
Octave Guinebretiere
,
Chloé Pierret
,
Quentin Calonge
,
Edouard Januel
,
Celine Louapre
et al.
Article dans une revue
hal-05034515
v1
|
|
|
Recurrence and Mortality After a First Status Epilepticus
Quentin Calonge
,
Octave Guinebretiere
,
Thomas Nedelec
,
Aurélie Hanin
,
Francois Le Gac
et al.
Article dans une revue
hal-05281729
v1
|
|
|
Validation study of “Santé-Cerveau”, a digital tool for early cognitive changes identification
Constance Lesoil
,
Stéphanie Bombois
,
Octave Guinebretiere
,
Marion Houot
,
Mahsa Bahrami
et al.
Article dans une revue
hal-04513299
v1
|
|
|
Association Between Diseases and Symptoms Diagnosed in Primary Care and the Subsequent Specific Risk of Multiple Sclerosis
Octave Guinebretiere
,
Thomas Nedelec
,
Laurène Gantzer
,
Beranger Lekens
,
Stanley Durrleman
et al.
Article dans une revue
hal-04330030
v1
|